BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24027087)

  • 1. Fractionation of the human plasma proteome for monoclonal antibody proteomics-based biomarker discovery 2: antigen identification by dot-blot array screening.
    Kovács A; Patai Z; Guttman A; Kádas J; Takács L; Kurucz I
    Electrophoresis; 2013 Nov; 34(20-21):3064-71. PubMed ID: 24027087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionation of the human plasma proteome for monoclonal antibody proteomics-based biomarker discovery.
    Kovács A; Sperling E; Lázár J; Balogh A; Kádas J; Szekrényes A; Takács L; Kurucz I; Guttman A
    Electrophoresis; 2011 Aug; 32(15):1916-25. PubMed ID: 21732557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody proteomics: use of antibody mimotope displaying phages and the relevant synthetic peptides for mAb scouting.
    Hajdú I; Flachner B; Bognár M; Végh BM; Dobi K; Lőrincz Z; Lázár J; Cseh S; Takács L; Kurucz I
    Immunol Lett; 2014 Aug; 160(2):172-7. PubMed ID: 24530813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative strategy for high throughput generation and characterization of monoclonal antibodies against human plasma proteins using fractionated native proteins as immunogens.
    Ning Y; Wang Y; Li Y; Hong Y; Peng D; Liu Y; Wang J; Hao W; Tian X; Wu F; Dong W; Wang L; Wu Q; Liu X; Gao J; He F; Qian X; Sun QH; Li M
    Proteomics; 2006 Jan; 6(2):438-48. PubMed ID: 16419015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicapillary SDS-gel electrophoresis for the analysis of fluorescently labeled mAb preparations: a high throughput quality control process for the production of QuantiPlasma and PlasmaScan mAb libraries.
    Székely A; Szekrényes A; Kerékgyártó M; Balogh A; Kádas J; Lázár J; Guttman A; Kurucz I; Takács L
    Electrophoresis; 2014 Aug; 35(15):2155-62. PubMed ID: 24838872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
    Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
    J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
    Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
    Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultradepletion of human plasma using chicken antibodies: a proof of concept study.
    Tan SH; Mohamedali A; Kapur A; Baker MS
    J Proteome Res; 2013 Jun; 12(6):2399-413. PubMed ID: 23082986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
    Stoevesandt O; Taussig MJ
    Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
    Lee HJ; Lee EY; Kwon MS; Paik YK
    Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-based generation and characterization of monoclonal antibodies against human liver mitochondrial proteins.
    Gao J; Gao Y; Ju Y; Yang J; Wu Q; Zhang J; Du X; Wang Z; Song Y; Li H; Luo X; Ren F; Li J; Chen Y; Wang L; Xu H; Liu X; Wang J; Zhang Y; Cai Y; Cui Y; Qian X; He F; Li M; Sun QH
    Proteomics; 2006 Jan; 6(2):427-37. PubMed ID: 16342244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
    Faca V; Pitteri SJ; Newcomb L; Glukhova V; Phanstiel D; Krasnoselsky A; Zhang Q; Struthers J; Wang H; Eng J; Fitzgibbon M; McIntosh M; Hanash S
    J Proteome Res; 2007 Sep; 6(9):3558-65. PubMed ID: 17696519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.
    Csanky E; Olivova P; Rajnavolgyi E; Hempel W; Tardieu N; Katalin ET; Jullien A; Malderez-Bloes C; Kuras M; Duval MX; Nagy L; Scholtz B; Hancock W; Karger B; Guttman A; Takacs L
    Electrophoresis; 2007 Dec; 28(23):4401-6. PubMed ID: 18041035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
    Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
    Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen identification and characterization of lung cancer specific monoclonal antibodies produced by mAb proteomics.
    Wang D; Hincapie M; Guergova-Kuras M; Kadas J; Takacs L; Karger BL
    J Proteome Res; 2010 Apr; 9(4):1834-42. PubMed ID: 20146545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers.
    Lazar J; Antal-Szalmas P; Kurucz I; Ferenczi A; Jozsi M; Tornyi I; Muller M; Fekete JT; Lamont J; FitzGerald P; Gall-Debreceni A; Kadas J; Vida A; Tardieu N; Kieffer Y; Jullien A; Guergova-Kuras M; Hempel W; Kovacs A; Kardos T; Bittner N; Csanky E; Szilasi M; Losonczy G; Szondy K; Galffy G; Csada E; Szalontai K; Somfay A; Malka D; Cottu P; Bogos K; Takacs L
    Mol Cell Proteomics; 2023 Jul; 22(7):100580. PubMed ID: 37211046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
    Zolotarjova N; Mrozinski P; Chen H; Martosella J
    J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins.
    Desrosiers RR; Beaulieu E; Buchanan M; Béliveau R
    Cell Biochem Biophys; 2007; 49(3):182-95. PubMed ID: 17952643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein profiling of human plasma samples by two-dimensional electrophoresis.
    Cho SY; Lee EY; Kim HY; Kang MJ; Lee HJ; Kim H; Paik YK
    Methods Mol Biol; 2008; 428():57-75. PubMed ID: 18287768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.